Stablishment of Prevention and Treatment System for Intestinal Dysfunction (A)

Nanjing University School of Medicine

Status and phase: Unknown; Phase 2; Phase 1

Conditions: Bowel Dysfunction

Treatments: Drug: Nutritional Therapy, Metabolic Disorder, Regular

Study type: Interventional

Funder types: Other

Identifiers

NCT04507945

Intestinal dysfunction

Details and patient eligibility

About

Dysfunction and intestinal endocrine dysfunction. This project will use genomics, metabonomics, microbiome and other omics techniques to study the clinical pathway of CID integrated therapy.

Enrollment: 50 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• The Patients with chronic bowel dysfunction

Exclusion criteria

• Past severe underlying diseases of the respiratory system and cardiovascular system,
• Allergy to treatment-related drugs,
• Pregnancy,
• Accept CID surgery.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind

---

50 participants in 2 patient groups

living quality

Experimental group

Treatment:

Drug: Nutritional Therapy, Metabolic Disorder, Regular

complication

Experimental group

Treatment:

Drug: Nutritional Therapy, Metabolic Disorder, Regular